ArcelorMittal announces publication of the 2025 statutory financial statements of ArcelorMittal parent company
Globenewswire· 2026-03-27 16:51
Group 1 - ArcelorMittal published its statutory financial statements for the year ended December 31, 2025, which are available on the Luxembourg Stock Exchange and the company's corporate website [1] - In 2025, ArcelorMittal generated revenues of $61.4 billion, produced 55.6 million metric tonnes of crude steel, and 48.8 million tonnes of iron ore [2] - The company operates in 60 countries, with primary steelmaking operations in 14 countries, making it the largest steel producer in Europe and a significant player in the Americas and Asia [2] Group 2 - ArcelorMittal aims to produce smarter steels that use less energy, emit significantly less carbon, and reduce costs, supporting the transition to renewable energy infrastructure [2] - The company has a diverse customer base, including industries such as automotive, engineering, construction, and machinery [2] - ArcelorMittal is listed on multiple stock exchanges, including New York, Amsterdam, Paris, Luxembourg, and various Spanish stock exchanges [3]
EUROAPI - Availability of the 2025 Universal Registration Document
Globenewswire· 2026-03-27 16:45
Group 1 - EUROAPI published its 2025 Universal Registration Document on March 27, 2026, filed with the French Autorité des marchés financiers (AMF) [1] - The document includes the annual financial report, management report, corporate governance report, sustainability statement, and consolidated statements [5] - The document is accessible on EUROAPI's website and the AMF website, made available to the public under regulatory conditions [1] Group 2 - EUROAPI focuses on reinventing active pharmaceutical ingredients to meet global customer and patient needs, with approximately 200 products in its portfolio [2] - The company has strong R&D capabilities and operates five manufacturing sites in Europe, providing high-quality API solutions in over 80 countries [3] - EUROAPI is committed to advancing public health by securing access to essential active ingredients, employing over 3,000 people [3]
SANOMA CORPORATION: ACQUISITION OF OWN SHARES 27 March 2026
Globenewswire· 2026-03-27 16:30
Acquisition of Own Shares - Sanoma Corporation executed a share buyback on 27 March 2026, acquiring 23,142 shares at an average price of EUR 9.0148 per share, with a total cost of EUR 208,620.50 [1] - The highest price per share during the buyback was EUR 9.0700, while the lowest was EUR 8.9500 [1] Shareholding Information - Following the buyback, Sanoma holds a total of 1,098,534 of its own shares [2] Company Overview - Sanoma is described as an innovative and agile learning and media company, impacting millions across Europe by providing high-quality learning content and solutions [2] - The company employs nearly 5,000 professionals and reported net sales of approximately EUR 1.3 billion in 2025, with an adjusted operating profit margin of 14.4% [5] Strategic Focus - Sanoma aims for organic growth in K12 education and plans to accelerate this growth through value-creating mergers and acquisitions [4] - The company is committed to sustainability, focusing on maximizing its positive impact on society while minimizing its environmental footprint, and is aligned with the UN Sustainable Development Goals [4]
ASM announces the availability of the 2026 AGM materials
Globenewswire· 2026-03-27 16:30
Group 1 - ASM International N.V. has announced the details for its Annual General Meeting (AGM) scheduled for May 11, 2026, including the convocation, agenda, and related documents available on its website [1][2] - The AGM will take place at 2:00 p.m. CET at the Van der Valk Hotel in Almere, Netherlands, allowing shareholders to attend in person or via a live webcast [2] - The record date for the AGM is set for April 13, 2026, with a total of 49,328,548 common shares issued, and 48,886,070 voting shares after accounting for treasury shares [2] Group 2 - The agenda for the AGM includes the approval of the annual accounts for 2025, a remuneration report for 2025, and a proposal to declare a regular dividend of €3.25 per common share [4] - The AGM will also address the reappointment of key management members, including Mr. M'Saad as CEO and Mr. De Jong to the Supervisory Board, along with changes to the remuneration policies for both boards [4] - EY Accountants B.V. is proposed for reappointment as the auditor and assurance provider for the financial year 2027 [4] Group 3 - ASM International N.V. is headquartered in Almere, Netherlands, and specializes in designing and manufacturing equipment and process solutions for semiconductor device production, with facilities across the U.S., Europe, and Asia [3]
Knight Therapeutics Inc. ranks on The Globe and Mail’s second annual Canada’s Top Growing Women-Led Companies and seventh annual Women Lead Here benchmark of executive gender diversity
Globenewswire· 2026-03-27 16:26
Core Insights - Knight Therapeutics Inc. has been recognized in two national benchmarks by The Globe and Mail's Report on Business magazine for 2026, highlighting its growth and commitment to gender diversity in leadership [1][2] Group 1: Recognition and Achievements - Knight Therapeutics is included in Canada's Top Growing Women-Led Companies for the first time, reflecting sustained growth and entrepreneurial spirit [1] - The company also received recognition in the Women Lead Here benchmark, which emphasizes progress in gender diversity among executive ranks [1][3] Group 2: Rankings and Methodology - Canada's Top Growing Women-Led Companies ranking, launched in 2025, evaluates businesses based on verified three-year revenue growth, requiring a minimum of $2 million in annual revenue [2] - The Women Lead Here benchmark, established in 2020, assesses large publicly-traded Canadian companies for gender diversity among executives, analyzing approximately 500 companies for the 2026 ranking [3][4] - For the 2026 Women Lead Here ranking, 85 companies achieved the seal, with an average of 56% of executive roles held by female-identifying individuals [5]
Cambridge Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing March 30, 2026
Globenewswire· 2026-03-27 16:22
Group 1 - Cambridge Acquisition Corp. announced that starting March 30, 2026, holders of units from its initial public offering can separately trade Class A ordinary shares and warrants [1] - The Class A ordinary shares will trade under the symbol "CAQ" and the warrants under "CAQUW" on the Nasdaq Global Market, while units that are not separated will continue to trade under "CAQUU" [1] - No fractional warrants will be issued upon the separation of the units, and only whole warrants will be available for trading [1] Group 2 - Cambridge Acquisition Corp. is a blank check company, also known as a special purpose acquisition company (SPAC), aimed at executing business combinations such as mergers and asset acquisitions [2]
Hofseth BioCare ASA: HBC ANNUAL REPORT 2025
Globenewswire· 2026-03-27 16:08
Core Insights - Hofseth BioCare ASA ("HBC") has approved its financial statements for 2025 and published its Annual Report and Sustainability Report for the same year [1] - The company successfully placed new ordinary shares with gross proceeds of NOK 158 million in October 2025, although the transaction is not yet completed due to technical and legal delays [1] - The completion of the share transaction is expected in Q2 2026, which will strengthen the company's balance sheet and support growth [1] Company Overview - HBC is a Norwegian consumer and pet health company focused on sustainability and optimal utilization of natural resources [2] - The company upcycles side streams from the salmon industry into health-improving ingredients such as ProGo®, OmeGo®, and CalGo® / NT-II® [2] Scientific and Health Benefits - HBC emphasizes scientific evidence, leading to academic partnerships and the identification of unique health benefits [3] - ProGo® enhances iron metabolism, OmeGo® supports immune health, and CalGo® promotes bone and joint health [3] Patents and Biotech Ventures - HBC has secured multiple patents for its discoveries and has established a biotech-focused subsidiary, HBC Immunology (HBCI), which is developing therapeutics for prostate and ovarian cancer, as well as an oral therapy for asthma [4] Company Listings - HBC is listed on Oslo Børs under the ticker "HBC" [5]
Jushi Holdings Inc. Refinances Former 1st Lien Credit Facility and Former 2nd Lien Credit Facility with US$160 Million Non-Dilutive Debt Financing
Globenewswire· 2026-03-27 16:03
Core Viewpoint - Jushi Holdings Inc. has successfully refinanced its previous credit facilities by issuing a $160 million senior secured term loan, enhancing its cash position and financial stability [1][2][3]. Financial Details - The term loan was issued at a 4.0% original issuance discount with an interest rate of 12.50% per annum, maturing three years from the issuance date [2]. - Following the refinancing, the company has approximately $35 million in cash, cash equivalents, and restricted cash as of March 27, 2026 [3]. Related Party Transactions - James Cacioppo, CEO and founder, participated in the term loan with approximately $28 million, while Denis Arsenault, a significant equity holder, contributed approximately $21 million [4]. - The refinancing involving related parties was considered a related party transaction under MI 61-101, and the company relied on exemptions from formal valuation and minority shareholder approval requirements [5][6]. Upcoming Financial Reporting - The company will report its fourth quarter 2025 financial results on March 31, 2026, and will host a conference call to discuss these results [7][8].
Moomoo and the New York Mets Enter Second Year of Strategic Partnership to Continue Enhancing the Fan Experience
Globenewswire· 2026-03-27 16:00
Core Insights - Moomoo and the New York Mets have renewed their strategic partnership for a second year, enhancing engagement between baseball fans and investors [2][4] - The partnership aims to create memorable experiences for fans while promoting financial education and community engagement [5][8] Group 1: Partnership Details - The partnership was first announced before the 2025 MLB season and focuses on connecting fans and investors through shared interests [2] - Moomoo will kick off the 2026 MLB season with on-site fan engagement activities at Citi Field during the home opener against the Pittsburgh Pirates [3] - The partnership includes a series of fan-focused experiences throughout the season, such as suite tickets for account holders who invite friends and enhanced in-stadium activations [6] Group 2: Company Overview - Moomoo is a global investment and trading platform with over 29 million users, recognized for its innovative approach and user-friendly tools [5][8] - The platform has expanded its presence to multiple markets, including Singapore, Australia, Japan, Canada, Malaysia, and New Zealand, and is a subsidiary of a Nasdaq-listed company [8] - Moomoo has been recognized as the 1 Broker for Stocks in North America in 2024 and 2025 by TradingView, highlighting its reliability and innovation in the financial sector [8]
NTG Nordic Transport Group A/S – Annual General Meeting 2026
Globenewswire· 2026-03-27 16:00
Core Points - NTG Nordic Transport Group A/S held its Annual General Meeting on March 27, 2026, where all proposals were adopted [1] - The audited Annual Report for 2025 was approved, and the net profit for the financial year ended December 31, 2025, was allocated to retained earnings with no dividend payment [1] - The Remuneration Report for 2025 and the remuneration for the Board of Directors for 2026 were approved [2] Board of Directors - All members of the Board of Directors were re-elected, including Eivind Drachmann Kolding (Chairman) and Jørgen Hansen (Deputy Chairman) [3][7] - PricewaterhouseCoopers was elected as NTG's auditor for financial and sustainability reporting [3] Share Capital and Articles of Association - The Board of Directors was authorized to increase the Company's share capital by up to DKK 90,597,620 until March 27, 2031, without pre-emption rights for existing shareholders [4] - Several articles regarding the issuance of warrants and other non-substantive updates to the Articles of Association were approved for deletion or amendment [5][6][8]